Besides immune cells, hematopoietic stem cells in myelodysplastic syndromes (MDS) [157] and leukemic stem cells (LSC) in acute myeloid leukemia (AML) can express TIM-3 [20, 158, 159]. Here, HAVCR2 is linked to acute myeloid leukemia.